CRM
ABBV icon

Cardano Risk Management’s AbbVie ABBV Stock Holding History

Cardano Risk Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143M Buy
569,015
+32,345
+6% +$6.96M 1.1% 26
2026
Q1 		$124M Sell
536,670
-7,823
-1% -$1.74M 1.22% 22
2025
Q4 		$124M Buy
544,493
+7,823
+1% +$1.78M 1.25% 20
2025
Q3 		$124M Buy
536,670
+12,629
+2% +$2.57M 1.32% 20
2025
Q2 		$97.3M Buy
524,041
+30,204
+6% +$5.61M 1.25% 25
2025
Q1 		$103M Buy
+493,837
New +$96M 1.65% 19

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Cardano Risk Management's ABBV Position: Q2 2026 in Review

Cardano Risk Management increased its AbbVie (ABBV) stake by 6% in Q2 2026, buying an estimated $6.96M and bringing the position to 569,015 shares worth $143M. The position accounts for 1.1% of the portfolio, ranked #26.

Cardano Risk Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cardano Risk Management held 569,015 shares of AbbVie worth $143M as of Q2 2026.
  • Cardano Risk Management bought 32,345 AbbVie shares in Q2 2026, an estimated $6.96M.
  • AbbVie made up 1.1% of Cardano Risk Management's portfolio in Q2 2026, its #26 holding.
  • Cardano Risk Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cardano Risk Management's 13F filing for Q2 2026, filed 9 Jul 2026.